Advertisement Allergan names new president - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Allergan names new president

Allergan, a multi-specialty health care company engaged in discovering, developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter consumer products, has reappointed David Pyott as the president of the company, effective 27 March 2011.

Additionally, Pyott will also continue to serve the company in his current roles as chairman of the board and CEO.

Additionally, the new structure will allow Mr Pyott to invest more of his efforts in the development of the strong bench of the company leaders and their teams.

Allergan Human Resources executive vice president Scott Sherman said the decision to create direct reporting lines between Pyott and Allergan’s commercial leaders, who have been with the company for decades and are responsible for the largest businesses, supports our commitment to talent development and succession planning, providing opportunities that will advance our next generation of leaders.